Hepatitis C Market Forecast

Publication Date	January 2009
Publisher	Datamonitor
Product Type	Interactive Model
Pages
ISBN Number	not applicable
Product Code	DAT14424

Buy this product or for assistance call +44 20 7060 7474

PDF £7,955.00$13232 | €8904

FAX Order above formats by FAX

Summary

Introduction
The Hepatitis C market was worth $2.3 billion in 2007, declining at a CAGR of -2.8% from 2004-2007. Despite this recent slump, Datamonitor forecasts sales to grow to $4.5 billion by 2017, driven primarily by the launch of the new protease inhibitors. The US and EU will remain the largest markets, generating $1.9 billion and $1.7 billion respectively in 2017.

Scope

Highlights

Reasons to Purchase

Understand current and future Hepatitis C market dynamics

Gain insight into the unmet needs of HCV patients and the extent to which pipeline drugs are addressing these issues

Assess current and future market size and the impact of new drug launches

Content

Please note that this product is delivered as an interactive model. The model is an Excel document and its data can be manipulated and used as per your needs. The data when extracted and used must be correctly cited to the publisher. This product does not include numbers of pages due to the format that it is supplied in. Should you have any queries regarding the model or would like a demo please do not hesitate to call us on Tel: +44 (0) 20 7060 7474 or email our customer service on service@reportbuyer.com